News & Updates

Laparoscopic pancreaticoduodenectomy is a safe procedure in elderly patients with periampullary tumours needing surgery, a recent study has found.

Upfront treatment with nivolumab plus chemotherapy continues to yield significant survival benefit compared with chemotherapy alone in patients with advanced GC/GEJC/EAC* after 24 months, regardless of their PD-L1 combined positive score (CPS), according to long-term data from the CheckMate-649 trial presented at GICS 2022.

Varlitinib demonstrate good antitumour activity and an acceptable safety profile in patients with advanced or metastatic solid organ tumours, according to a recent Singapore study.

Surgical resection of recurrent oesophageal squamous cell carcinoma lesions after curative esophagectomy may be beneficial, especially for cases with lower pN stage, lung metastasis, and long recurrence-free interval, according to a study.

New drug applications approved by US FDA as of 16-28 February 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Endoscopic resection (ER) is a safe and effective management approach for oesophageal granular cell tumours (GCT), yielding high rates of procedural success and low long-term mortality and complications, a recent study has found.